RT Magazine’s annual Product Guide, which includes more than 60 of the newest respiratory care products from 50 leading manufacturers, is now available on our enhanced mobile application for tablets and smartphones.
With the help of a $2.4 million grant from the National Institutes of Health, a Virginia Tech professor is working on a vaccine that could help smokers conquer their nicotine addiction.
The guidelines address old and new pharmacological and nonpharmacological therapies available for prevention of COPD exacerbations.
Capnographic monitoring to detect early changes in breathing during routine colonoscopy does not capture more episodes of hypoxemia in moderately sedated healthy adults.
Monitoring devices among ICU patients set off 2.5 million alarms in one month at UCSF Medical Center, a new study of “alarm fatigue” shows.
Children who have had enterovirus are at increased risk for developing type 1 diabetes compared with children who have not had the virus.
An increase in fractional exhaled nitric oxide was more strongly associated with occupational asthma caused by high-molecular-weight agents than with low-molecular-weight agents.
Sunovion Pharmaceuticals Inc will present new data highlighting the efficacy and safety results of SUN-101 (glycopyrrolate inhalation solution), a long-acting muscarinic antagonist (LAMA) bronchodilator in development for the treatment of COPD.
Electronic Cigarettes International is scheduled to begin trading on the Nasdaq Friday.
A new study found that Anoro Ellipta ((umeclidinium /vilanterol) showed a statistically significant improvement in lung function compared with tiotropium for COPD patients.
Enteroviruses normally occur late every summer and into every fall, but as temperatures drop, the reason for concern decreases.